336 related articles for article (PubMed ID: 22464730)
21. A mechanistic view of the role of E3 in sumoylation.
Tozluoğlu M; Karaca E; Nussinov R; Haliloğlu T
PLoS Comput Biol; 2010 Aug; 6(8):. PubMed ID: 20865051
[TBL] [Abstract][Full Text] [Related]
22. Structural basis for E2-mediated SUMO conjugation revealed by a complex between ubiquitin-conjugating enzyme Ubc9 and RanGAP1.
Bernier-Villamor V; Sampson DA; Matunis MJ; Lima CD
Cell; 2002 Feb; 108(3):345-56. PubMed ID: 11853669
[TBL] [Abstract][Full Text] [Related]
23. Importin-β and CRM1 control a RANBP2 spatiotemporal switch essential for mitotic kinetochore function.
Gilistro E; de Turris V; Damizia M; Verrico A; Moroni S; De Santis R; Rosa A; Lavia P
J Cell Sci; 2017 Aug; 130(15):2564-2578. PubMed ID: 28600321
[TBL] [Abstract][Full Text] [Related]
24. In situ SUMOylation analysis reveals a modulatory role of RanBP2 in the nuclear rim and PML bodies.
Saitoh N; Uchimura Y; Tachibana T; Sugahara S; Saitoh H; Nakao M
Exp Cell Res; 2006 May; 312(8):1418-30. PubMed ID: 16688858
[TBL] [Abstract][Full Text] [Related]
25. Performing in vitro sumoylation reactions using recombinant enzymes.
Werner A; Moutty MC; Möller U; Melchior F
Methods Mol Biol; 2009; 497():187-99. PubMed ID: 19107418
[TBL] [Abstract][Full Text] [Related]
26. Identification of a SUMO-binding motif that recognizes SUMO-modified proteins.
Song J; Durrin LK; Wilkinson TA; Krontiris TG; Chen Y
Proc Natl Acad Sci U S A; 2004 Oct; 101(40):14373-8. PubMed ID: 15388847
[TBL] [Abstract][Full Text] [Related]
27. Molecular Characterization and Functional Analysis of Annulate Lamellae Pore Complexes in Nuclear Transport in Mammalian Cells.
Raghunayakula S; Subramonian D; Dasso M; Kumar R; Zhang XD
PLoS One; 2015; 10(12):e0144508. PubMed ID: 26642330
[TBL] [Abstract][Full Text] [Related]
28. The RanGAP1-RanBP2 complex is essential for microtubule-kinetochore interactions in vivo.
Joseph J; Liu ST; Jablonski SA; Yen TJ; Dasso M
Curr Biol; 2004 Apr; 14(7):611-7. PubMed ID: 15062103
[TBL] [Abstract][Full Text] [Related]
29. Impairments in age-dependent ubiquitin proteostasis and structural integrity of selective neurons by uncoupling Ran GTPase from the Ran-binding domain 3 of Ranbp2 and identification of novel mitochondrial isoforms of ubiquitin-conjugating enzyme E2I (ubc9) and Ranbp2.
Patil H; Yoon D; Bhowmick R; Cai Y; Cho KI; Ferreira PA
Small GTPases; 2019 Mar; 10(2):146-161. PubMed ID: 28877029
[TBL] [Abstract][Full Text] [Related]
30. Protection from isopeptidase-mediated deconjugation regulates paralog-selective sumoylation of RanGAP1.
Zhu S; Goeres J; Sixt KM; Békés M; Zhang XD; Salvesen GS; Matunis MJ
Mol Cell; 2009 Mar; 33(5):570-80. PubMed ID: 19285941
[TBL] [Abstract][Full Text] [Related]
31. Biochemical characterization of SUMO-conjugating enzymes by in vitro sumoylation assays.
Eisenhardt N; Ilic D; Nagamalleswari E; Pichler A
Methods Enzymol; 2019; 618():167-185. PubMed ID: 30850051
[TBL] [Abstract][Full Text] [Related]
32. Functional modulation of parkin through physical interaction with SUMO-1.
Um JW; Chung KC
J Neurosci Res; 2006 Nov; 84(7):1543-54. PubMed ID: 16955485
[TBL] [Abstract][Full Text] [Related]
33. In Vitro SUMOylation Assay to Study SUMO E3 Ligase Activity.
Yang WS; Campbell M; Kung HJ; Chang PC
J Vis Exp; 2018 Jan; (131):. PubMed ID: 29443041
[TBL] [Abstract][Full Text] [Related]
34. Identification of a non-covalent ternary complex formed by PIAS1, SUMO1, and UBC9 proteins involved in transcriptional regulation.
Mascle XH; Lussier-Price M; Cappadocia L; Estephan P; Raiola L; Omichinski JG; Aubry M
J Biol Chem; 2013 Dec; 288(51):36312-27. PubMed ID: 24174529
[TBL] [Abstract][Full Text] [Related]
35. SUMO-1 targets RanGAP1 to kinetochores and mitotic spindles.
Joseph J; Tan SH; Karpova TS; McNally JG; Dasso M
J Cell Biol; 2002 Feb; 156(4):595-602. PubMed ID: 11854305
[TBL] [Abstract][Full Text] [Related]
36. Fourier transform ion cyclotron resonance mass spectrometry for the analysis of small ubiquitin-like modifier (SUMO) modification: identification of lysines in RanBP2 and SUMO targeted for modification during the E3 autoSUMOylation reaction.
Cooper HJ; Tatham MH; Jaffray E; Heath JK; Lam TT; Marshall AG; Hay RT
Anal Chem; 2005 Oct; 77(19):6310-9. PubMed ID: 16194093
[TBL] [Abstract][Full Text] [Related]
37. Sumoylation of human argonaute 2 at lysine-402 regulates its stability.
Sahin U; Lapaquette P; Andrieux A; Faure G; Dejean A
PLoS One; 2014; 9(7):e102957. PubMed ID: 25036361
[TBL] [Abstract][Full Text] [Related]
38. MEL-18 interacts with HSF2 and the SUMO E2 UBC9 to inhibit HSF2 sumoylation.
Zhang J; Goodson ML; Hong Y; Sarge KD
J Biol Chem; 2008 Mar; 283(12):7464-9. PubMed ID: 18211895
[TBL] [Abstract][Full Text] [Related]
39. RWD Domain as an E2 (Ubc9)-Interaction Module.
Alontaga AY; Ambaye ND; Li YJ; Vega R; Chen CH; Bzymek KP; Williams JC; Hu W; Chen Y
J Biol Chem; 2015 Jul; 290(27):16550-9. PubMed ID: 25918163
[TBL] [Abstract][Full Text] [Related]
40. Structural and dynamic independence of isopeptide-linked RanGAP1 and SUMO-1.
Macauley MS; Errington WJ; Okon M; Schärpf M; Mackereth CD; Schulman BA; McIntosh LP
J Biol Chem; 2004 Nov; 279(47):49131-7. PubMed ID: 15355965
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
